Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $20.40 -0.52 (-2.49%) As of 06/12/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock Neoleukin Therapeutics Stock Price Performance The Neoleukin Therapeutics (NLTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.13%, with a year-to-date return of -11.19%. In the past month, the stock has increased 15.25%, reflecting recent market activity. As of the latest close, Neoleukin Therapeutics traded at $20.92 with a market cap of $196.61 million and volume of 133,476 shares. Five years ago, the stock traded at a split-adjusted price of $252.40, representing a 91.92% decrease over that period. At the time, it had a market cap of $555.26 million and a volume of 18,300 shares. Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.99%1 Month Performance+15.25%3 Month Performance+14.74%Year-To-Date Performance-11.19%1 Year Performance-45.13%5 Year Performance-91.92% NLTX Stock Chart for Friday, June, 13, 2025 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$21.58$20.92-3.06%$22.00$20.68133,476 shs$196.61 million06/11/2025$19.91$21.58+8.39%$21.73$19.25128,823 shs$202.81 million06/10/2025$21.83$19.91-8.80%$21.89$19.13245,841 shs$187.11 million06/09/2025$21.83$21.83$25.19$21.50224,694 shs$205.16 million06/06/2025$21.67$22.92+5.77%$23.20$20.46335,616 shs$215.40 million06/05/2025$20.56$21.67+5.40%$23.14$20.33264,828 shs$203.66 million06/04/2025$17.75$20.56+15.83%$20.78$17.71422,714 shs$193.22 million06/03/2025$17.01$17.75+4.35%$18.45$16.62210,536 shs$166.81 million06/02/2025$17.01$17.01$18.84$16.87228,470 shs$159.86 million05/30/2025$17.66$18.74+6.12%$18.90$17.14149,292 shs$176.12 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$17.09$17.66+3.34%$18.04$16.86128,976 shs$165.97 million05/28/2025$17.28$17.09-1.10%$17.74$16.75167,843 shs$160.61 million05/27/2025$17.28$17.28$17.84$16.95110,750 shs$162.40 million05/26/2025$17.28$17.28$17.84$16.95110,750 shs$162.40 million05/23/2025$18.55$18.04-2.75%$18.38$17.0591,478 shs$169.54 million05/22/2025$18.55$18.55$20.39$18.03205,195 shs$174.33 million05/21/2025$19.52$18.55-4.97%$20.39$18.03205,195 shs$174.33 million05/20/2025$17.99$19.52+8.50%$20.16$17.28239,144 shs$183.45 million05/19/2025$17.99$17.99$18.89$15.68313,270 shs$169.07 million05/16/2025$15.22$19.37+27.27%$19.51$14.85510,895 shs$182.04 million05/15/2025$15.51$15.22-1.87%$15.88$14.72119,549 shs$143.04 million05/14/2025$17.70$15.51-12.37%$17.73$15.28158,307 shs$145.76 million05/13/2025$14.73$17.70+20.16%$17.75$13.93363,717 shs$166.35 million05/12/2025$14.73$14.73$16.00$13.69173,021 shs$138.43 million Related Companies Pharming Group Stock Price Chart Immunome Stock Price Chart ArriVent BioPharma Stock Price Chart Chimerix Stock Price Chart Avid Bioservices Stock Price Chart Gyre Therapeutics Stock Price Chart Cogent Biosciences Stock Price Chart Replimune Group Stock Price Chart Cronos Group Stock Price Chart Vir Biotechnology Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
